Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Receptor Tyrosine Kinase Fusions and BRAF Kinase Fusions are Rare but Actionable Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors

PaperCitations, authors & open-access status

Receptor Tyrosine Kinase Fusions and BRAF Kinase Fusions are Rare but Actionable Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 137 citations, 2018 year and hybrid oa status.

137
Citations
2018
Year
hybrid
OA Status

Related on ScholarIQ

Ben Creelan
Author
Journal of Thoracic Oncology
Journal
Lung Cancer Treatments and Mutations
Topic
Lung Cancer Treatments and Mutations
Topic
HER2/EGFR in Cancer Research
Topic
Colorectal Cancer Treatments and Studies
Topic
470M+ articles · free account